MedPath

A Randomized Controlled Clinical Study To Edvaluate The Efficicacy Of Siravedha And Eranda Taila Orally In Vatakanatak With Special Reference To Reference To Plantar Fasciitis.

Phase 3
Conditions
Health Condition 1: M708- Other soft tissue disorders related to use, overuse and pressure
Registration Number
CTRI/2024/02/062253
Lead Sponsor
Dr Dipali Rohidas Shinde
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients will be selected irrespective of sex, chronicity.

2. patients of age group 18-60 suffering from only vatakanatak (Plantar Fasciitis).

3. patients with pratyatma lakshana of vatakanatak vyadhi i.e pain in plantar aspect of heel, tenderness.

4. patients having pain at plantar region in presence of normal plain radiograph of foot (AP & lateral view).

Exclusion Criteria

1. Anarhas of siravedha mentioned in classics.

2. Patients having uncontrolled DM, HTN or any severe systemic diseases.

3. calcaneal stress fracture.

4. The patients clinically assessed with impaired circulation to lower extremities.

5. Patients with referred pain due to sciatica & other neurological disorders.

6. Bleeding disorders.

7. Those patients who need other emergency interventions like surgery and other means are excluded.

8. Anaemic patients.

9. HIV, HBSAG reactive patients are also excluded.

10. Malignant & immunocompromised patients are also excluded.

11. patients on treatment of anticoagulants

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduced pain in plantar regionTimepoint: 16 days
Secondary Outcome Measures
NameTimeMethod
1. Reduced tenderness in plantar region <br/ ><br>2. Normal movements of ankle jointsTimepoint: 17 days
© Copyright 2025. All Rights Reserved by MedPath